Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19

SHIJIAZHUANG, China, April 14, 2020 /PRNewswire/ — On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Lianhua Qingwen capsules and Lianhua Qingwen granules issued by State Drug Administration. Lianhua Qingwen capsule and […]

Read more